Circulating Levels of Pealbumin in Relation to Overweight or Obesity

Independent Relationship Between Prealbumin and Circulating Levels of Parathormone Triglycerides and FT3 in Subjects With Overweight or Obesity

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04333446

Enrollment

Registered

2020-04-03

Start date

2019-01-07

Completion date

2019-12-31

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The study was aimed to investigating the relationship between circulating level of prealbumin and parathormone (PTH), triglycerides and triiodothyronine (FT3) in overweight and obese subjects (BMI≥25 Kg/m2)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Overweight or obesity (BMI\> 25 Kg/m2)

Exclusion criteria

* Any kind of drug Hypertension Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), Chronic inflammatory diseases Renal failure Liver failure Angina pectoris Myocardial infarction and heart failure Genetic heart diseases Thrombocytopenias

Design outcomes

Primary

Measure	Time frame	Description
Free Triiodothyronine (FT3)	baseline	FT3 (pg/mL) concentration in serum
Parathormone (PTH)	baseline	PTH (pg/mL) concentration in serum
Triglycerides	baseline	Triglycerides (mg/dl) concentration in serum
Prealbumin	baseline	Prealbumin (g/L) concentration in serum

Secondary

Measure	Time frame	Description
Body mass Index (BMI)	baseline	BMI (kg/m\^2)
Height	baseline	Height in meters
Weight	baseline	Weight in kilograms

Countries

Italy

Outcome results